THE RELATIONSHIP BETWEEN FLAVONOIDS AND CANCER

Ayam Al anisi; Hasan Jasim Hami; Mohammed M. Barrak

doi:10.61796/jmgcb.v1i7.740

Authors

Ayam Al anisi
nono2013118@gmail.com
Education Directorate of Thi-Qar, Ministry of Edueatron, Iraq
Hasan Jasim Hami Department of Biology/ College of Science/ University of Thi-Qar.
Mohammed M. Barrak Department of Anatomy and Biology, Faculty of Medicine, University of Wasit, Wasit, Iraq

Vol. 1 No. 7 (2024): Journal of Medical Genetics and Clinical Biology

Articles

July 13, 2024

Downloads

View Article

Abstract
How to Cite
Metrics
References
License

Flavonoids are the effective ingredients of the compounds found in grains, vegetables, fruits, seeds and some drinks that have medicinal, free radical reducing and anti-cancer functions. In plants, flavonoids play an important role in multiple functions including color formation, growth, and protection against damage and microorganisms. Articles have stated that the molecular functions of flavonoids may improve health and reduce disease symptoms, reduce antibiotic resistance and reduce inflammation in humans. One of the features of such research is the potential effect of flavonoids on cancer risk.Chemically, flavonoids have an overall 15-carbon skeletal structure consisting of two phenyl rings and one heterocyclic ring. This carbon structure can be abbreviated as C6-C3-C6. Flavonoids are the effective ingredients of the compounds found in grains, vegetables, fruits, seeds and some drinks that have medicinal, free radical reducing and anti-cancer functions. In plants, flavonoids play an important role in multiple functions including color formation, growth, and protection against damage and microorganisms. Articles have stated that the molecular functions of flavonoids may improve health and reduce disease symptoms, reduce antibiotic resistance and reduce inflammation in humans. One of the features of such research is the potential effect of flavonoids on cancer risk.

. Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, et al. Important flavonoids and their role as a therapeutic agent. Molecules (Basel, Switzerland). 2020;25(22):5243.

. Dias MC, Pinto DC, Silva AM. Plant flavonoids: Chemical characteristics and biological activity. Molecules (Basel, Switzerland). 2021;26(17):5377.

. Shen N, Wang T, Gan Q, Liu S, Wang L, Jin B. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity. Food chemistry. 2022;383:132531.

. Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. Flavonoids in cancer metastasis. Cancers. 2020;12(6):1498.

. Hazafa A, Rehman K-U-, Jahan N, Jabeen Z. The role of polyphenol (flavonoids) compounds in the treatment of cancer cells. Nutrition and cancer. 2020;72(3):386-97.

. Hosseinzadeh E, Hassanzadeh A, Marofi F, Alivand MR, Solali S. Flavonoid-based cancer therapy: an updated review. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2020;20(12):1398-414.

. Khan AU, Dagur HS, Khan M, Malik N, Alam M, Mushtaque M. Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives. European Journal of Medicinal Chemistry Reports. 2021;3:100010.

. Sudhakaran M, Doseff AI. The targeted impact of flavones on obesity-induced inflammation and the potential synergistic role in cancer and the gut microbiota. Molecules (Basel, Switzerland). 2020;25(11):2477.

. McCarty MF, Assanga SI, Lujan LL. Flavones and flavonols may have clinical potential as CK2 inhibitors in cancer therapy. Medical hypotheses. 2020;141:109723.

. Yang J, Shen H, Mi M, Qin Y. Isoflavone consumption and risk of breast cancer: An updated systematic review with meta-analysis of observational studies. Nutrients. 2023;15(10):2402.

. Boutas I, Kontogeorgi A, Dimitrakakis C, Kalantaridou SN. Soy isoflavones and breast cancer risk: a meta-analysis. in vivo. 2022;36(2):556-62.

. Fan Y, Wang M, Li Z, Jiang H, Shi J, Shi X, et al. Intake of soy, soy isoflavones and soy protein and risk of cancer incidence and mortality. Frontiers in Nutrition. 2022;9:847421.

. Hatono M, Ikeda H, Suzuki Y, Kajiwara Y, Kawada K, Tsukioki T, et al. Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments. Breast Cancer Research and Treatment. 2021;185:307-16.

. Selepe MA, Kunyane P, Seboletswe P, Nair S, Cele N, Engelbrecht M, et al. Synthesis and evaluation of benzoylbenzofurans and isoflavone derivatives as sirtuin 1 inhibitors with antiproliferative effects on cancer cells. Bioorganic Chemistry. 2022;128:106101.

. Almatroodi SA, Alsahli MA, Almatroudi A, Verma AK, Aloliqi A, Allemailem KS, et al. Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways. Molecules (Basel, Switzerland). 2021;26(5):1315.

. Felice MR, Maugeri A, De Sarro G, Navarra M, Barreca D. Molecular pathways involved in the anti-cancer activity of flavonols: a focus on myricetin and kaempferol. International Journal of Molecular Sciences. 2022;23(8):4411.

. Kubina R, Iriti M, Kabała-Dzik A. Anticancer potential of selected flavonols: Fisetin, kaempferol, and quercetin on head and neck cancers. Nutrients. 2021;13(3):845.

. Sharma A, Kumar A, Tuli HS, Khare R, Sharma AK. Flavan-3-Ols Research: From Chemistry to Nanomedicine. Nanotechnology Horizons in Food Process Engineering: Apple Academic Press; 2023. p. 39-75.

. Di Pede G, Mena P, Bresciani L, Achour M, Lamuela-Raventós RM, Estruch R, et al. Revisiting the bioavailability of flavan-3-ols in humans: A systematic review and comprehensive data analysis. Molecular Aspects of Medicine. 2023;89:101146.

. Márquez Campos E, Jakobs L, Simon M-C. Antidiabetic effects of flavan-3-ols and their microbial metabolites. Nutrients. 2020;12(6):1592.

. Favari C, Mena P, Curti C, Del Rio D, Angelino D. Flavan‐3‐ols: Catechins and Proanthocyanidins. Dietary Polyphenols: Their Metabolism and Health Effects. 2020:283-317.

. Padilla-González GF, Grosskopf E, Sadgrove NJ, Simmonds MS. Chemical diversity of Flavan-3-Ols in grape seeds: Modulating factors and quality requirements. Plants. 2022;11(6):809.

. Devkota HP, Adhikari-Devkota A, Paudel KR, Panth N, Chellappan DK, Hansbro PM, et al. Tea (catechins including (−)-epigallocatechin-3-gallate) and cancer. Nutraceuticals and Cancer Signaling: Clinical Aspects and Mode of Action. 2021:451-66.

. Alfke J, Kampermann U, Esselen M. HPLC-MS/MS quantification of flavan-3-ols, xanthines, and epigallocatechin-3-gallate oxidation products in tea samples and new insights into their cytotoxicity. ACS Food Science & Technology. 2022;2(5):925-35.

. Bimonte S, Cascella M, Barbieri A, Arra C, Cuomo A. Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge. Infectious agents and cancer. 2020;15:1-6.

. Drețcanu G, Știrbu I, Leoplold N, Cruceriu D, Danciu C, Stănilă A, et al. Chemical structure, sources and role of bioactive flavonoids in cancer prevention: a review. Plants. 2022;11(9):1117.

. Oruganti L, Meriga B. Plant polyphenolic compounds potentiates therapeutic efficiency of anticancer chemotherapeutic drugs: A review. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2021;21(2):246-52.

. Shams SGE, Eissa RG. Amelioration of ethanol-induced gastric ulcer in rats by quercetin: implication of Nrf2/HO1 and HMGB1/TLR4/NF-κB pathways. Heliyon. 2022;8(10).

. Zoi V, Galani V, Lianos GD, Voulgaris S, Kyritsis AP, Alexiou GA. The role of curcumin in cancer treatment. Biomedicines. 2021;9(9):1086.

. Barrak MM, Al-Aidy SR, Bonyadi M. Unraveling DREAM-PL: A Case Report on Challenges and Management. University of Thi-Qar Journal of Science. 2024 Jun 1;11(1):33-5.

. Riyas NR, Kazm MK, Ubaid AQ, Barrak MM. Applications of Biophysics in the Understanding and Treatment of Cellular Diseases. Innovative: International Multidisciplinary Journal of Applied Technology (2995-486X). 2024 Jun 15;2(5):100-14.

. Barrak MM, Bonyadi M, Hami HJ, Al Ali MD, Muttair RY, Abd RA. Exploring the Heterogeneity of Non-Syndromic Hearing Loss: A Comprehensive Review of Implicated Genes and the Role of Whole Exome Sequencing. University of Thi-Qar Journal of Science. 2023 Dec 27;10(2):192-9.

. Ali MD, Barrak MM, Salman RI, Sa'doon NM. The combined effect of artemisia absinthium methanolic extract and vinblastine chemotherapy on apoptosis and decreasing chemotherapy drug concentration. InAIP Conference Proceedings 2023 Sep 13 (Vol. 2845, No. 1). AIP Publishing.